FRANKFURT (Business) – German healthcare and chemicals company Merck KGaAreports that it may face a slight dip in operating earnings with the coronavirus pandemic placing a significant burden on the global economy.
Their earnings before interest, taxes, depreciation and amortisation (EBITDA) will mostly be in the 4.35 billion euros to 4.85 billion euros range, as compared to 4.39 billion last year.
Adjusted EBITDA went up 27% to 1.2 billion euros beyond the average analyst estimate of 1.1 billion euros.
(Photo syndicated via Reuters)
This story has been edited by BH staff and is published from a syndicated field.